¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

¼¼ºê¶õ½ºº´¿ø (¿Â¶óÀÎ) ¼¼ºê¶õ½º °£ ½ÉÆ÷Áö¾ö : 2022-02-12

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
¼¼ºê¶õ½ºº´¿ø (¿Â¶óÀÎ) ¼¼ºê¶õ½º °£ ½ÉÆ÷Áö¾ö : 2022-02-12
±³À°ÀÏÀÚ : 2022-02-12
±³À°Àå¼Ò : ½ºÀ§½º±×·£µåÈ£ÅÚ  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) ¼¼ºê¶õ½º °£ ½ÉÆ÷Áö¾ö
ÁÖÃÖ±â°ü : ¼¼ºê¶õ½ºº´¿ø
´ã´çÀÚ : ±èÁø¾Æ
¿¬¶ôó : 02-2228-5223  
À̸ÞÀÏ : lccrc1208@yuhs.ac      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 20ºÐ  
¼¼ºÎ¼ö°­·á : 0¿ø      
ºñ°í       

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 02-12 ½ºÀ§½º±×·£µåÈ£ÅÚWhite Heron 09:00~09:25 Current status and future perspectives of NA therapy in CHB  ÀÓÇüÁØ(°í·Á´ë) 
±³À°½Ã°£ 02-12 ½ºÀ§½º±×·£µåÈ£ÅÚWhite Heron 09:25~09:50 HCC risk after HBsAg loss  ½Åµ¿Çö(¼º±Õ°ü´ë) 
±³À°½Ã°£ 02-12 ½ºÀ§½º±×·£µåÈ£ÅÚWhite Heron 09:50~10:15 Clinical research on chronic viral hepatitis utilising electronic medical records in Hong Kong  Terry Cheuk-Fung Yip(Faculty of Medicine The Chinese University of Hong Kong Hong Kong) 
±³À°½Ã°£ 02-12 ½ºÀ§½º±×·£µåÈ£ÅÚWhite Heron 10:15~10:40 Establishment of a nationwide prospective Korean CHB cohort  ÀÌÀç½Â(¿¬¼¼´ë) 
Åä·Ð 02-12 ½ºÀ§½º±×·£µåÈ£ÅÚWhite Heron 10:40~10:50 Discussion  () 
È޽Ġ02-12 ½ºÀ§½º±×·£µåÈ£ÅÚWhite Heron 10:50~11:00 Session break  () 
±³À°½Ã°£ 02-12 ½ºÀ§½º±×·£µåÈ£ÅÚWhite Heron 11:00~11:25 Fat does matter?  Àü´ë¿ø(ÇѾç´ë) 
±³À°½Ã°£ 02-12 ½ºÀ§½º±×·£µåÈ£ÅÚWhite Heron 11:25~11:50 Follow-up or not to follow-up NAFLD patients  ÀÌÇý¿ø(¿¬¼¼´ë) 
±³À°½Ã°£ 02-12 ½ºÀ§½º±×·£µåÈ£ÅÚWhite Heron 11:50~12:15 Association between NAFLD and CKD  Á¤Âù¿µ(¿¬¼¼´ë) 
±³À°½Ã°£ 02-12 ½ºÀ§½º±×·£µåÈ£ÅÚWhite Heron 12:15~12:40 Influence of exercise on NAFLD  ÀüÈ£¼ö(ÀÌÈ­¿©´ë) 
Åä·Ð 02-12 ½ºÀ§½º±×·£µåÈ£ÅÚWhite Heron 12:40~12:50 Discussion  () 
½Ä»ç 02-12 ½ºÀ§½º±×·£µåÈ£ÅÚWhite Heron 12:50~13:30 Lunch  () 
±³À°½Ã°£ 02-12 ½ºÀ§½º±×·£µåÈ£ÅÚWhite Heron 13:30~13:55 Implication of YAP/TAZ signaling and novel therapeutic targets  ³ë¿ø»ó(°æÈñ´ë) 
±³À°½Ã°£ 02-12 ½ºÀ§½º±×·£µåÈ£ÅÚWhite Heron 13:55~14:20 Breakthrough in HCC surveillance: perspective of MR surveillance  ÀÌÇüÁø(¿¬¼¼´ë) 
±³À°½Ã°£ 02-12 ½ºÀ§½º±×·£µåÈ£ÅÚWhite Heron 14:20~14:45 Immunological classification of HCC  ±èÇý·É(¼­¿ï´ë) 
±³À°½Ã°£ 02-12 ½ºÀ§½º±×·£µåÈ£ÅÚWhite Heron 14:45~15:10 Application of artificial intelligence in HCC diagnosis  ±è¼º¿ø(¿¬¼¼´ë) 
Åä·Ð 02-12 ½ºÀ§½º±×·£µåÈ£ÅÚWhite Heron 15:10~15:20 Discussion  () 
È޽Ġ02-12 ½ºÀ§½º±×·£µåÈ£ÅÚWhite Heron 15:20~15:30 Session break  () 
±³À°½Ã°£ 02-12 ½ºÀ§½º±×·£µåÈ£ÅÚWhite Heron 15:30~15:55 How far can criteria be expanded in living donor liver transplantation?  ÁÖµ¿Áø(¿¬¼¼´ë) 
±³À°½Ã°£ 02-12 ½ºÀ§½º±×·£µåÈ£ÅÚWhite Heron 15:55~16:20 Yttrium-90 transarterial radioembolization: 13-year experiences in Severance Hospital  ±è°æ¹Î(¿¬¼¼´ë) 
±³À°½Ã°£ 02-12 ½ºÀ§½º±×·£µåÈ£ÅÚWhite Heron 16:20~16:45 Novel radiation therapy: Carbon ion for HCC  ¼ºÁø½Ç(¿¬¼¼´ë) 
±³À°½Ã°£ 02-12 ½ºÀ§½º±×·£µåÈ£ÅÚWhite Heron 16:45~17:10 Systemic therapy for HCC: TKI vs. checkpoint inhibitor  TBD() 
Åä·Ð 02-12 ½ºÀ§½º±×·£µåÈ£ÅÚWhite Heron 17:10~17:20 Discussion  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ¼¼ºê¶õ½ºº´¿ø (¿Â¶óÀÎ) ¼¼ºê¶õ½º °£ ½ÉÆ÷Áö¾ö : 2022-02-12""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û °Ç¾ç´ëÇб³º´¿ø KMT (Konyang-Mayo-Tokyo) 2022 : 2022-02-12
´ÙÀ½±Û 2022³â Á¦ 27 ȸ ¼­¿ïÀÇ´ë »êºÎÀΰúÇб³½Ç ÃÊÀ½ÆÄ ¿öÅ©¼¥ : 2022-02-12
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20694 ´ëÀü Á¦8ȸ ³»ºÐºñ ÃÊÀ½ÆÄ ¹× ±â´É°Ë»ç ¿¬¼ö°­Á : 2024-06-29 0 64 2024-05-11
20693 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29 0 39 2024-05-11
20692 ¼­¿ï Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28 0 47 2024-05-11
20691 °æ±â Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26 0 53 2024-05-11
20690 ¼­¿ï (¿Â¶óÀÎ)2024 ÇѾç´ëÇб³º´¿ø È£Èí±â¾Ë·¹¸£±â ¿¬¼ö°­Á : 2024-06-22 0 43 2024-05-11
20689 ºÎ»ê °í½Å´ëÇб³º¹À½º´¿ø Á¦20ȸ °©»ó¼±¿¬¼öȸ : 2024-06-22 0 41 2024-05-11
20688 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 3Â÷ : 2024-06-22 0 17 2024-05-11
20687 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (2ÀÏÂ÷) : 2024-06-22 0 17 2024-05-11
20686 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 2 : 2024-06-21 0 35 2024-05-11
20685 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (1ÀÏÂ÷) : 2024-06-21 0 20 2024-05-11
20684 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 1 : 2024-06-20 0 18 2024-05-11
20683 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) ¼­¿ï°æÀÎÁöȸ 277Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-18 0 42 2024-05-11
20682 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦3Â÷ ¿¬¼ö±³À°(¿°Áõ¼º ÀåÁúȯ,ºñ¸¸ ¾à¹° Ä¡·á ) : 2024-06-17 0 30 2024-05-11
20681 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ¿¬¼ö°­Á : 2024-06-16 0 32 2024-05-11
20680 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 2Â÷ : 2024-06-15 0 25 2024-05-11
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷